Core Insights - The article discusses the benefits of investing in dividend reinvestment plans (DRIPs) and highlights 14 affordable DRIP stocks to consider for investment [1][4]. Group 1: Dividend Reinvestment Plans - DRIPs automatically reinvest dividends and capital gains to purchase additional shares, often without extra costs, leading to compounded growth over time [2]. - This strategy is particularly favored by younger investors and those with longer investment horizons, as it simplifies the investment process and aligns with dollar-cost averaging principles [3]. Group 2: Methodology for Stock Selection - The selection process for the 14 DRIP stocks involved using stock screeners to identify dividend stocks with P/E ratios below 25 as of March 31, focusing on companies that offer DRIPs and have reported significant developments [6]. Group 3: Company-Specific Insights - **S&P Global Inc. (NYSE:SPGI)**: Appointed Firdaus Bhathena as Executive Vice President and Chief Technology and Transformation Officer, effective April 27, 2026, to enhance technology adoption and transformation [9][10]. - **Automatic Data Processing, Inc. (NASDAQ:ADP)**: TD Cowen and Wells Fargo have adjusted their price targets for ADP, reflecting changes in market conditions and expectations ahead of Q3 results [12][13]. - ADP raised its fiscal 2026 revenue growth outlook to approximately 6% and adjusted EPS growth to between 9% and 10%, supported by share repurchases [14]. The Employer Services segment is expected to deliver around 6% revenue growth for the year [15].

Core Viewpoint - A class action lawsuit has been filed against Aldeyra Therapeutics, Inc. for securities fraud, with the Rosen Law Firm representing investors who purchased securities between November 3, 2023, and March 16, 2026 [1]. Group 1: Lawsuit Details - The lawsuit alleges that during the Class Period, Aldeyra made false and misleading statements regarding the clinical trials of its drug candidate reproxalap, leading to unreliable positive findings [5]. - Investors who purchased Aldeyra securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Investors wishing to join the class action must move the Court by May 29, 2026, to serve as lead plaintiff, representing other class members in the litigation [3]. - The Rosen Law Firm encourages investors to select qualified counsel with a successful track record in securities class actions [4].

Company Performance - Superior Group (SGC) ended the recent trading session at $10.16, showing a +1.09% change from the previous day's closing price, but lagged behind the S&P 500's daily gain of 2.91% [1] - Over the past month, shares of Superior Group gained 0.9%, outperforming the Consumer Discretionary sector's loss of 9.16% and the S&P 500's loss of 7.64% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.02, which is a 140% increase from the prior-year quarter, with a projected revenue of $137.9 million, reflecting a 0.58% rise from the same quarter last year [2] - For the entire fiscal year, earnings are projected at $0.58 per share and revenue at $576.45 million, representing changes of +26.09% and +1.81% respectively from the prior year [3] Analyst Estimates and Rankings - Recent changes in analyst estimates for Superior Group are crucial as they reflect short-term business trends, with positive revisions indicating a favorable business outlook [3] - The Zacks Rank system currently rates Superior Group at 4 (Sell), with a 23.01% decrease in the consensus EPS estimate over the last 30 days [5] Valuation Metrics - Superior Group is trading at a Forward P/E ratio of 17.33, which is a premium compared to the industry average Forward P/E of 16.18 [6] - The company has a PEG ratio of 1.73, while the average PEG ratio for the Textile - Apparel industry is 2.02 [6] Industry Context - The Textile - Apparel industry is part of the Consumer Discretionary sector and holds a Zacks Industry Rank of 156, placing it in the bottom 37% of all industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - T. Rowe Price (TROW) ended the recent trading session at $90.14, showing a +1.25% change from the previous day's closing price, which lagged behind the S&P 500's daily gain of 2.91% [1] - Over the last month, T. Rowe Price shares have decreased by 6.21%, outperforming the Finance sector's loss of 7.75% and the S&P 500's loss of 7.64% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with T. Rowe Price forecasted to report an EPS of $2.44, reflecting a 9.42% increase from the same quarter last year [2] - The consensus estimate for quarterly revenue is $1.88 billion, which is a 6.49% increase from the year-ago period [2] Fiscal Year Projections - For the entire fiscal year, Zacks Consensus Estimates project earnings of $10.04 per share and revenue of $7.63 billion, indicating changes of +3.29% and +4.37% respectively from the prior year [3] - Recent changes to analyst estimates for T. Rowe Price are noteworthy, as they often indicate shifts in near-term business trends [3] Valuation Metrics - T. Rowe Price is currently trading at a Forward P/E ratio of 8.87, which is a discount compared to its industry's Forward P/E of 9.66 [5] - The PEG ratio for T. Rowe Price stands at 3.73, while the Financial - Investment Management industry has an average PEG ratio of 0.83 [6] Industry Ranking - The Financial - Investment Management industry, part of the Finance sector, has a Zacks Industry Rank of 167, placing it within the bottom 32% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Equinix (EQIX) is set to report its earnings soon, with positive projections for both EPS and revenue growth compared to the previous year [2][3]. Company Performance - In the latest trading session, Equinix's stock increased by 1.68% to $980.24, underperforming the S&P 500, which rose by 2.91% [1]. - Over the past month, Equinix shares have decreased by 0.21%, while the Finance sector and S&P 500 have seen losses of 7.75% and 7.64%, respectively [1]. Earnings Projections - The upcoming EPS for Equinix is projected at $10.72, reflecting a 10.86% increase year-over-year [2]. - Revenue is expected to reach $2.51 billion, indicating a growth of 12.76% compared to the same quarter last year [2]. - For the annual period, earnings are anticipated to be $41.93 per share, with revenue projected at $10.18 billion, representing increases of 9.39% and 10.49% respectively [3]. Analyst Estimates - Recent changes in analyst estimates for Equinix are crucial as they reflect short-term business trends and can influence share price momentum [4][5]. - The Zacks Rank system, which evaluates these estimate changes, currently rates Equinix as 2 (Buy) [6]. Valuation Metrics - Equinix has a Forward P/E ratio of 22.99, which is higher than the industry average of 13.7 [7]. - The company’s PEG ratio stands at 2.21, compared to the industry average PEG ratio of 2.58 [8]. Industry Context - Equinix operates within the REIT and Equity Trust - Retail industry, which is part of the Finance sector and holds a Zacks Industry Rank of 18, placing it in the top 8% of over 250 industries [9].

Core Insights - Innovative Industrial Properties (IIPR) closed at $50.16, reflecting a -1.18% change from the previous day, underperforming the S&P 500's gain of 2.91% [1] - Over the past month, IIPR shares have decreased by 5.44%, which is better than the Finance sector's decline of 7.75% and the S&P 500's drop of 7.64% [1] Earnings Performance - The upcoming EPS for IIPR is projected at $1.78, indicating an 8.25% decrease compared to the same quarter last year [2] - Revenue is expected to be $66.9 million, reflecting a 6.73% decline from the year-ago quarter [2] - For the annual period, earnings are anticipated to be $7.33 per share and revenue at $269.85 million, showing increases of +1.24% and +1.46% respectively from the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for IIPR are crucial as they indicate changing business trends [4] - Positive changes in estimates suggest a favorable outlook on the company's health and profitability [4] Stock Performance and Valuation - The Zacks Rank system, which incorporates estimate changes, currently rates IIPR as 3 (Hold) [6] - The Forward P/E ratio for IIPR is 6.92, which is a discount compared to the industry average of 11.04 [7] - The REIT and Equity Trust - Other industry, part of the Finance sector, holds a Zacks Industry Rank of 88, placing it in the top 36% of over 250 industries [7] Industry Insights - The Zacks Industry Rank evaluates the performance of industry groups based on the average Zacks Rank of individual stocks [8] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Group 1 - The article does not provide any specific content related to company or industry analysis [1]

Core Viewpoint - Resverlogix Corp. is currently under a management cease trade order application due to delays in completing its annual financial statements audit, which has resulted in a default on the filing deadline [1][2]. Group 1: Management Cease Trade Order (MCTO) Update - The application for the MCTO is still under review by the Alberta Securities Commission (ASC), with no decision made yet [1]. - The company has defaulted on the March 31, 2026 deadline for filing its annual audited financial statements and related documents due to the auditor's inability to complete the audit on time [1][2]. - The company is working with the auditor to resolve initial delays and is optimistic about completing the annual filings by April 10, 2026, although this cannot be assured [2]. Group 2: Implications of the Default - If the MCTO is granted, the CEO and CFO will be prohibited from trading the company's securities, while the general public can continue trading the company's common shares [3]. - The company is committed to satisfying the alternative information guidelines under NP 12-203, including issuing bi-weekly default status reports until the annual filings are completed [4]. Group 3: Company Background - Resverlogix, founded in 2001, is a Calgary-based late-stage biotechnology company specializing in epigenetics and aims to develop first-in-class therapies for chronic diseases [6]. - The company is focused on its lead epigenetic candidate, apabetalone, for treating cardiovascular disease and related conditions [7]. - Resverlogix's common shares are traded on the Toronto Stock Exchange under the ticker RVX [8].

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from “Algernon Health Inc.” to “Grey Matters Health Inc.” (the “Name Change”). The Company has reserved the new name and new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new symbols for the OTCQB and Frankfurt exchange will be provided shortl ...

Core Viewpoint - Richtech Robotics is facing a securities class action lawsuit following a significant drop in its stock price after a report indicated that Microsoft denied a commercial partnership with the company [1][6]. Group 1: Lawsuit Details - The lawsuit aims to represent investors who acquired Richtech securities between January 27, 2026, and January 29, 2026, after the stock price fell over 20% due to the news from Hunterbrook Media [1][2]. - Hagens Berman, a national shareholder rights law firm, has initiated an investigation into the claims that Richtech violated federal securities laws [2]. Group 2: Company Announcements and Market Reaction - On January 27, 2026, Richtech announced a collaboration with Microsoft, which initially led to a 30% increase in its stock price due to perceived commercial potential [4]. - The following day, Richtech disclosed a dilutive private placement of 8.5 million Class B common shares, raising concerns about the timing and implications of the announcement [5]. - On January 29, 2026, Hunterbrook Media reported that Microsoft characterized the engagement as a standard customer program without commercial elements, leading to a rapid decline in Richtech's stock price [6]. Group 3: Allegations and Investigative Focus - The lawsuit alleges that Richtech misled investors regarding the nature of its relationship with Microsoft, suggesting a more substantial partnership than existed [5][7]. - Hagens Berman's investigation is focused on whether Richtech intentionally misled investors to facilitate the equity raise and if this constitutes a new form of "AI washing" [7].